ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 133 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,000 | +11.6% | 1,396,555 | +15.1% | 0.01% | +50.0% |
| Q2 2023 | $4,479 | +39.1% | 1,213,735 | +24.7% | 0.01% | +50.0% |
| Q1 2023 | $3,221 | +19.3% | 973,235 | +39.8% | 0.00% | 0.0% |
| Q4 2022 | $2,700 | -99.8% | 695,935 | +9.0% | 0.00% | +100.0% |
| Q3 2022 | $1,551,000 | +8.0% | 638,400 | -12.0% | 0.00% | 0.0% |
| Q2 2022 | $1,436,000 | +49.0% | 725,500 | +37.7% | 0.00% | +100.0% |
| Q1 2022 | $964,000 | +95.9% | 526,700 | +51.0% | 0.00% | 0.0% |
| Q4 2021 | $492,000 | +85.0% | 348,900 | +48.5% | 0.00% | – |
| Q3 2021 | $266,000 | -5.3% | 235,000 | +33.8% | 0.00% | – |
| Q2 2021 | $281,000 | -76.0% | 175,626 | -6.7% | 0.00% | -100.0% |
| Q3 2018 | $1,169,000 | +785.6% | 188,300 | +544.9% | 0.00% | – |
| Q2 2018 | $132,000 | +109.5% | 29,200 | +43.8% | 0.00% | – |
| Q3 2017 | $63,000 | +50.0% | 20,300 | +79.6% | 0.00% | – |
| Q2 2017 | $42,000 | – | 11,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |